Position in ANVS
as of Sep 30, 2026
· filed Oct 8, 2026
Position Value
$2,668
-$1,239 QoQ
Shares Held
2,101
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 2 holders
Holding Since
Mar 2026
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Sep 30, 2026CoreCap Advisors, LLC holds $2,863,721 across 75 Biotechnology names. ANVS ranks #31 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
12,114 | $707,578 | |
| 2 | MRNA |
Moderna, Inc.
|
3,324 | $640,102 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
618 | $323,096 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
249 | $188,809 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
603 | $188,359 | |
| 6 | ANIX |
Anixa Biosciences Inc
|
62,020 | $181,718 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
280 | $141,108 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
457 | $93,803 |
All Filings in ANVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $2,668 | 2,101 | Shares | Sole | 2026-10-08 | |
| 2026-06-30 | $3,907 | 2,101 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $4,685 | 2,101 | Shares | Sole | 2026-04-07 | |
| No filing history on record for this holder in this stock. | ||||||